Clinical trial tracker

Clinical trial tracker

Looking for Lilly’s LY4086940? Its two registered trials, NCT06945419 and NCT07890376, are listed below. For what they test and what has not been disclosed, see the LY4086940 profile or our LY4086940 write-up.

Reset

1 registered trial, newest registry update first. Showing only trials linked to Semaglutide.

TrialCompoundPhaseStatusSponsorEnrolledPrimary completionRegistry updated
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
NCT05371496
SemaglutidePhase 4CompletedMayo Clinic81Jul 17, 2026Aug 14, 2026

Data: ClinicalTrials.gov, U.S. National Library of Medicine. Registered trials only. This table does not report results or recommend anything.